What is the market doing?
What the tape says about AMGN
Amgen is +59% over the past year while the S&P 500 is +23%: 37 points ahead of the market.
+59%
1-year return · S&P 500 +23%
- vs 200-day average
- +27%
vs 200-day average · a clear uptrend
- RSI (14)
- 75
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −0.78%
Below its 52-week high
Details›
- Last close2026-08-26
- $440.34
- 1 monthS&P 500 +3.7%
- +19%
- 1 yearS&P 500 +23%
- +59%
- 5 yearsS&P 500 +87%
- +113%
- vs 50-day average$377.50
- +17%
- 52-week high
- $443.80
- 52-week low
- $265.40
- Annualised volatility
- 28%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$22M
| Year | Return |
|---|---|
| 2026 (year to date) | +36% |
| 2025 | +30% |
| 2024 | −6.8% |
| 2023 | +13% |
| 2022 | +20% |
| 2021 | +0.87% |
| 2020 | −2.0% |
| 2019 | +28% |
| 2018 | +15% |
| 2017 | +22% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +2.5% |
| Feb | 10 | 5 of 10 | +0.64% |
| Mar | 10 | 6 of 10 | +0.45% |
| Apr | 10 | 2 of 10 | −0.57% |
| May | 10 | 3 of 10 | +0.42% |
| Jun | 10 | 8 of 10 | +2.8% |
| Jul | 11 | 10 of 11 | +5.1% |
| Aug | 11 | 7 of 11 | +3.2% |
| Sep | 10 | 4 of 10 | −1.3% |
| Oct | 10 | 3 of 10 | −1.5% |
| Nov | 10 | 8 of 10 | +4.2% |
| Dec | 10 | 5 of 10 | −0.13% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #5 of 16 by Smart Score